Vanguard Group Inc Elevation Oncology, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,071,580 shares of ELEV stock, worth $1.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,071,580
Previous 1,917,043 60.22%
Holding current value
$1.75 Million
Previous $5.18 Million 64.41%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$0.56 - $3.02 $646,540 - $3.49 Million
1,154,537 Added 60.22%
3,071,580 $1.84 Million
Q2 2024

Aug 13, 2024
BUY
$2.35 - $5.17 $904,745 - $1.99 Million
384,998 Added 25.13%
1,917,043 $5.18 Million
Q1 2024

May 10, 2024
BUY
$0.59 - $5.13 $212,871 - $1.85 Million
360,799 Added 30.8%
1,532,045 $7.86 Million
Q4 2023

Feb 14, 2024
BUY
$0.38 - $0.69 $38,547 - $69,994
101,441 Added 9.48%
1,171,246 $632,000
Q3 2023

Nov 14, 2023
SELL
$0.65 - $1.56 $3,478 - $8,349
-5,352 Reduced 0.5%
1,069,805 $706,000
Q2 2023

Aug 14, 2023
BUY
$1.4 - $5.06 $867,126 - $3.13 Million
619,376 Added 135.89%
1,075,157 $1.63 Million
Q1 2023

May 15, 2023
BUY
$0.75 - $2.55 $91,854 - $312,306
122,473 Added 36.74%
455,781 $865,000
Q4 2022

Feb 10, 2023
BUY
$0.89 - $1.19 $252 - $337
284 Added 0.09%
333,308 $316,000
Q3 2022

Nov 14, 2022
SELL
$1.03 - $1.53 $69,863 - $103,778
-67,829 Reduced 16.92%
333,024 $376,000
Q2 2022

Aug 12, 2022
BUY
$1.26 - $3.94 $31,122 - $97,318
24,700 Added 6.57%
400,853 $561,000
Q1 2022

May 13, 2022
SELL
$2.34 - $6.41 $10,904 - $29,870
-4,660 Reduced 1.22%
376,153 $948,000
Q4 2021

Feb 14, 2022
SELL
$4.15 - $8.86 $1.14 Million - $2.43 Million
-274,596 Reduced 41.9%
380,813 $2.29 Million
Q3 2021

Nov 12, 2021
BUY
$7.66 - $16.11 $4.56 Million - $9.59 Million
595,409 Added 992.35%
655,409 $5.11 Million
Q2 2021

Aug 13, 2021
BUY
$11.44 - $13.57 $686,400 - $814,200
60,000 New
60,000 $814,000

Others Institutions Holding ELEV

# of Institutions
68
Shares Held
45.4M
Call Options Held
700
Put Options Held
27.6K
View Full List

About Elevation Oncology, Inc.

ELEV Quotes by TradingView
  • Ticker ELEV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,300,900
  • Market Cap $13.3M
  • Description
  • Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...
More about ELEV
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email